BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) was down 0.7% during trading on Friday . The company traded as low as $1.44 and last traded at $1.45. Approximately 4,886 shares changed hands during trading, a decline of 99% from the average daily volume of 713,020 shares. The stock had previously closed at $1.46.
BioRestorative Therapies Price Performance
The stock has a market capitalization of $10.03 million, a PE ratio of -0.95 and a beta of 62.52. The firm’s 50 day simple moving average is $1.55 and its 200 day simple moving average is $1.61.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.
Recommended Stories
- Five stocks we like better than BioRestorative Therapies
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- How to Choose Top Rated Stocks
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- The Basics of Support and Resistance
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
